| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 20.682.927 | 20.568.679 | 30.309.668 | 35.380.764 | 46.466.157 | 37.233.077 | 41.729.296 | 55.525.179 | 69.635.368 | 72.953.068 |
| Total Income - EUR | 22.522.185 | 22.419.167 | 31.988.268 | 36.751.075 | 48.073.319 | 38.569.106 | 42.627.753 | 58.545.317 | 71.479.698 | 74.374.741 |
| Total Expenses - EUR | 20.743.144 | 20.037.288 | 25.306.777 | 28.416.594 | 34.846.407 | 31.844.231 | 38.670.659 | 46.268.875 | 56.126.429 | 61.862.634 |
| Gross Profit/Loss - EUR | 1.779.042 | 2.381.879 | 6.681.491 | 8.334.481 | 13.226.912 | 6.724.874 | 3.957.094 | 12.276.443 | 15.353.269 | 12.512.107 |
| Net Profit/Loss - EUR | 1.507.466 | 2.154.995 | 6.112.024 | 7.329.691 | 11.495.708 | 6.081.167 | 3.552.995 | 10.747.765 | 14.523.397 | 12.172.195 |
| Employees | 276 | 280 | 321 | 380 | 396 | 424 | 449 | 466 | 500 | 559 |
Check the financial reports for the company - Rompharm Company Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 13.199.995 | 12.844.157 | 15.391.435 | 14.540.764 | 14.814.544 | 16.125.769 | 19.207.690 | 21.526.854 | 30.386.061 | 37.699.089 |
| Current Assets | 17.001.707 | 22.274.343 | 27.630.414 | 32.435.073 | 43.552.752 | 48.871.041 | 54.033.218 | 67.923.833 | 73.987.002 | 88.157.243 |
| Inventories | 5.841.150 | 5.908.381 | 7.377.252 | 10.348.891 | 11.316.984 | 13.858.715 | 16.830.031 | 19.074.727 | 22.511.896 | 23.634.608 |
| Receivables | 11.030.736 | 15.932.705 | 19.548.922 | 20.655.458 | 29.869.609 | 34.189.539 | 35.888.040 | 41.426.568 | 46.146.855 | 59.042.460 |
| Cash | 129.821 | 433.257 | 704.240 | 1.430.724 | 2.366.159 | 822.788 | 1.315.146 | 7.422.538 | 5.328.251 | 5.480.176 |
| Shareholders Funds | 6.383.973 | 8.519.749 | 14.548.464 | 20.750.296 | 31.829.769 | 37.303.448 | 36.633.412 | 47.452.621 | 61.826.122 | 76.344.699 |
| Social Capital | 6.772 | 6.703 | 6.589 | 6.468 | 6.343 | 6.223 | 6.085 | 6.104 | 6.085 | 6.051 |
| Debts | 23.857.717 | 26.632.660 | 28.504.815 | 26.302.751 | 26.592.996 | 27.813.647 | 36.665.827 | 42.040.140 | 42.425.234 | 49.459.515 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "2110 - 2110" | |||||||||
| CAEN Financial Year |
2110
|
|||||||||
Comments - Rompharm Company Srl